Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Bio Blast Pharma Ltd Company Profile (NASDAQ:ORPN)

Consensus Ratings for Bio Blast Pharma Ltd (NASDAQ:ORPN) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $23.50 (280.87% upside)

Analysts' Ratings History for Bio Blast Pharma Ltd (NASDAQ:ORPN)
Show:
DateFirmActionRatingPrice TargetDetailsShare
11/26/2014OppenheimerReiterated RatingOutperform$32.00ViewTweet This Rating  Share This Rating on StockTwits
8/25/2014Roth CapitalInitiated CoverageBuy$15.00ViewTweet This Rating  Share This Rating on StockTwits
8/25/2014OppenheimerInitiated CoverageOutperform$32.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 12/19/2012 forward)